Omomyc as the first MYC-targeted theraphy to succesfully complete a phase I clinical trial

by VHIO

Omomyc, a mini-therapeutic protein developed at the Vall d'Hebron Institute of Oncology (VHIO), has been shown in the preclinical phase in the laboratory to be able to enter cells and reach their nucl...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Curapath highlights its collaboration wi...

by Curapath

Curapath is pleased to acknowledge the significant progress achieved b...

Photos Stream